Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar(Michigan Center for Translational Pathology), Laila Poisson(Cancer Research And Biostatistics), Thekkelnaycke M. Rajendiran(Michigan Center for Translational Pathology), Amjad Khan(Michigan Center for Translational Pathology), Qi Cao(Michigan Center for Translational Pathology), Jindan Yu(Michigan Center for Translational Pathology), Bharathi Laxman(Michigan Center for Translational Pathology), Rohit Mehra(Michigan Center for Translational Pathology), Robert J. Lonigro(Comprehensive Blood & Cancer Center), Yong Li(Michigan Center for Translational Pathology), Mukesh K. Nyati(Comprehensive Blood & Cancer Center), Aarif Ahsan, Shanker Kalyana‐Sundaram(Michigan Center for Translational Pathology), Bo Han(Michigan Center for Translational Pathology), Xuhong Cao(Michigan Center for Translational Pathology), Jaeman Byun, Gilbert S. Omenn(Computational Physics (United States)), Debashis Ghosh(Cancer Research And Biostatistics), Subramaniam Pennathur(Computational Physics (United States)), Danny C. Alexander(Metabolon (United States)), Alvin Berger(Metabolon (United States)), Jeffrey R. Shuster(Metabolon (United States)), John T. Wei(Comprehensive Blood & Cancer Center), Sooryanarayana Varambally(Michigan Center for Translational Pathology), Chris Beecher(Michigan Center for Translational Pathology), Arul M. Chinnaiyan(Computational Physics (United States))
Cited by 2,242Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis